A1 Refereed original research article in a scientific journal

Alpha-Cyperone Mitigates Renal Ischemic Injury via Modulation of HDAC-2 Expression in Diabetes : Insights from Molecular Dynamics Simulations and Experimental Evaluation




AuthorsDaude Rakesh B., Bhadane Rajendra, Shah Jigna S.

PublisherElsevier

Publication year2024

JournalEuropean Journal of Pharmacology

Journal name in sourceEuropean journal of pharmacology

Journal acronymEur J Pharmacol

Article number176643

Volume975

ISSN0014-2999

eISSN1879-0712

DOIhttps://doi.org/10.1016/j.ejphar.2024.176643

Web address https://doi.org/10.1016/j.ejphar.2024.176643


Abstract
Chronic diabetes mellitus is reported to be associated with acute kidney injury. The enzyme histone deacetylase-2 (HDAC-2) was found to be upregulated in diabetes-related kidney damage. Alpha-cyperone (α-CYP) is one of the active ingredients of Cyperus rotundus that possesses antioxidant and anti-inflammatory effects. We evaluated the effect of α-CYP on improving oxidative stress and tissue inflammation following renal ischemia/reperfusion (I/R) injury in diabetic rats. The effect of α-CYP on HDAC-2 expression in renal homogenates and in the NRK-52E cell line was evaluated following renal I/R injury and high glucose conditions, respectively. Molecular docking was used to investigate the binding of α-CYP with the HDAC-2 active site. Both renal function and oxidative stress were shown to be impaired in diabetic rats due to renal I/R injury. Significant improvements in kidney/body weight ratio, creatinine clearance, serum creatinine, blood urea nitrogen (BUN), and uric acid were observed in diabetic rats treated with α-CYP (50 mg/kg) two weeks prior to renal I/R injury. α-CYP treatment also improved histological alterations in renal tissue and lowered levels of malondialdehyde, myeloperoxidase, and hydroxyproline. Treatment with α-CYP suppressed the increased HDAC-2 expression in the renal tissue of diabetic rats and in the NRK-52E cell line. The molecular docking reveals that α-CYP binds to HDAC-2 with good affinity, ascertained by molecular dynamics simulations and binding free energy analysis. Overall, our data suggest that α-CYP can effectively prevent renal injury in diabetic rats by regulating oxidative stress, tissue inflammation, fibrosis and inhibiting HDAC-2 activity.


Funding information in the publication
No funding.


Last updated on 2024-28-11 at 11:57